Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Soft Tissue Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04464967
What this trial is testing

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Who this might be right for
Advanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more
NKGen Biotech, Inc.
Testing effectiveness (Phase 2)Study completedNCT01946529
What this trial is testing

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Who this might be right for
Desmoplastic Small Round Cell TumorEwing Sarcoma of Bone or Soft TissueLocalized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+1 more
St. Jude Children's Research Hospital 24
Early research (Phase 1)Study completedNCT05538572
What this trial is testing

PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerGlioblastomaHead and Neck Squamous Cell Carcinoma+4 more
Prelude Therapeutics Incorporated 22
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Not applicableLooking for participantsNCT04693377
What this trial is testing

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the Bone+15 more
M.D. Anderson Cancer Center 40
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Study completedNCT03454451
What this trial is testing

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more
Corvus Pharmaceuticals, Inc. 117
Testing effectiveness (Phase 2)Looking for participantsNCT05726383
What this trial is testing

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

Who this might be right for
Osteogenic Sarcoma Recurrent
Hackensack Meridian Health 32
Early research (Phase 1)Ended earlyNCT02408861
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more
National Cancer Institute (NCI) 79
Not applicableStudy completedNCT00993694
What this trial is testing

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Vanderbilt University 41
Early research (Phase 1)Study completedNCT03126591
What this trial is testing

Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 41
Large-scale testing (Phase 3)Ended earlyNCT02929394
What this trial is testing

Trabectedin Maintenance Post 1st-line in STS

Who this might be right for
Sarcoma, Soft Tissue
European Organisation for Research and Treatment of Cancer - EORTC 13
Not applicableEnded earlyNCT02720796
What this trial is testing

Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma

Who this might be right for
Sarcoma
Champions Oncology 17
Early research (Phase 1)Ended earlyNCT04900766
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma

Who this might be right for
Unresectable or Metastatic Bone and Soft Tissue Sarcoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 31
Early research (Phase 1)Looking for participantsNCT07633756
What this trial is testing

A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy

Who this might be right for
Phase 1bOpen LabelREC-617+2 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)Study completedNCT01391962
What this trial is testing

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Who this might be right for
Sarcoma, Alveolar Soft Part
National Cancer Institute (NCI) 34
Next Page